We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Itaconix Plc | LSE:ITX | London | Ordinary Share | GB00BPK3YZ68 | ORD 50P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 153.00 | 146.00 | 160.00 | 153.00 | 148.00 | 153.00 | 536 | 08:00:26 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Chemicals & Chem Preps, Nec | 5.6M | -2.46M | -0.1826 | -8.38 | 20.63M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/10/2019 14:17 | Pug - have said this before. We have enough cash till april/ May as costs have come down a lot over last one year and we continue to increase revenue.Yes we may raise funds early next year( possibly January/february) but imo will be higher than today's share price. | jungmana | |
20/10/2019 14:07 | Jungman- Subject of course that they do not need further funding and that the pipeline delivers - Do you agree with the cash burn calculations in 2242 above? These are as you can see based on both Proactives forecasts and the latest rns? if not why not. | pugugly | |
20/10/2019 13:40 | for new investors good research piece by Proactive. as noted there itx is undervalued compared to peers in the speciality chemicals industry; "We argue that the market values these types of companies relative to their addressable market size, rather than on a one-year or two-year forward revenue multiple. On this basis, we believe that the current valuation of Itaconix leaves significant upside." | jungmana | |
20/10/2019 13:02 | But with a potential cash call comjng | rhatton | |
20/10/2019 12:47 | So unless my maths is out the eqivalent share price now would be about 5.9p? | ivor hunch | |
20/10/2019 11:25 | Exactly 2 years ago itx was trading about 20p and had roughly 80m shares in issue ( about GBP 16m market cap).The company has taken huge leaps forward since 2017 with end of research and development phase, trimming of business, reduction in costs And signing partnerships with 3 big majors.But now sitting at 1.6p with about 270m shares in issue (about GBP 4.5m market cap).Excellent investment opportunity at this level imo | jungmana | |
20/10/2019 10:38 | 31m invested in development all secured with 42 granted patents. All IP available for a little over 4m.Itaconix are the world leader in bio-based polymers from itaconic acid. Combining the versatile chemistry of itaconic acid with breakthrough economics, we are establishing a pipeline of polymers that compete on unique functionality and cost advantages in home care, industrial markets and personal care.From Pfizer in the 1960's to Rohm & Haas in the 1990's, leading polymer chemists have recognized the potential of polyitaconates with the functionality of its two distinct carboxylic acid groups but have been unable to identify an economic manufacturing process.The 2004 US Department of Energy Bio-Based Chemical Report highlighted itaconic acid as one of the top 12 value added chemicals from biomass, and identified its polymerization as the key barrier to commercial success.Itaconix have developed a process with breakthrough economics and low capital investment. Using its ability to produce itaconic acid polymers at competitive costs, Itaconix is developing a growing line of high-value products through the use and modification of the unique acid groups to achieve desired properties that meet specific customer or market needs. | lukehold | |
19/10/2019 17:51 | dex, ideally Wednesday | the patient investor | |
19/10/2019 14:39 | Gets a mention in the Daily Mail's Stockwatch.Summary of news yesterday with a coloured chart and of course Neil W. | geraldus | |
19/10/2019 14:33 | TPI, I hope you're not hoping to retire any time soon then.... | dexdringle | |
19/10/2019 14:17 | Sorry 40million market cap at DCTA | wololol | |
19/10/2019 14:16 | I think Investors as well need to look at other companies with similar IP and their valuations. Directa Plus 60million market cap and still not in profit. There are several others as well. Where is the info about 31 million Luke I'd be interested to research that more. I think we are going to have a strong rally soon especially after seeing the demand on Friday. Great recovery and grewl entry point for new investors . I think true value is around 5p at the moment. | wololol | |
19/10/2019 13:42 | itx is my retirement fund ;-) | the patient investor | |
19/10/2019 12:42 | Doubled holding on dip yesterday. 31m investment in developing and getting patented, in demand products to market. Rewards just starting to take shape, all available for 4.3m | lukehold | |
18/10/2019 17:22 | Yay, that's what I wanted to see - a big after-hours trade! 1.5M there. Let's hope we get an RNS on Monday saying that Spreadex are out, or that it's a director buy?NAI | cyberbub | |
18/10/2019 13:25 | Thanks for the latest vid.Look forward to achieving critical mass. | geraldus | |
18/10/2019 13:09 | Yes thanks for posting | value viper | |
18/10/2019 11:47 | Brilliant, thx parob | the patient investor | |
18/10/2019 11:37 | Video interview with John Shaw just out.Polymers specialist Itaconix 'accelerating' revenue post trading update2019-10-18 11:13:00hTTps://tiny | parob | |
18/10/2019 10:49 | very good point rivaldo, i still see blue today | the patient investor | |
18/10/2019 10:27 | Funnily enough today's news could do us a big favour. The fall has brought in decent buying interest which will have cleared the Spreadex overhang that much more quickly than otherwise. If and when positive news is announced, then with a mere £4m m/cap and not many shares available the price reaction would be interesting. | rivaldo | |
18/10/2019 10:03 | This is a disappointing update IMO. At least the market doesn't seem to have taken it too hard though... So far.Let's hope for more sales growth soon. At least it's good that they are giving us more regular updates.What we could do with now is the directors buying another few mill to show confidence. | cyberbub | |
18/10/2019 09:43 | can we have 2p please | the patient investor |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions